Forte Biosciences, Inc. · NASDAQ:FBRX
Alger Associates, Inc. reported a 10.20% stake in Forte Biosciences, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Alger Associates, Inc. reported a 10.20% stake in Forte Biosciences, Inc., 624,286 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 10.20%
- Shares
- 624,286
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Alger Associates, Inc. | 10.20% | 624,286 |
Source
Related
- Forte Biosciences, Inc.
- Alger Associates, Inc.
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Alger Associates, Inc. · Aug 7, 2026
- Schedule 13G/A · Alger Associates, Inc. · Nov 14, 2025
- Schedule 13G/A · Alger Associates, Inc. · Aug 14, 2025
- Schedule 13G/A · Alger Associates, Inc. · May 15, 2025
- Schedule 13G/A · Alger Associates, Inc. · Feb 14, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026
- Form 4 · Kornfeld Steven · Aug 27, 2026
- Form 4 · Gryska David W · Aug 27, 2026
- Form 4 · Riley Antony A · Aug 27, 2026
- Form 4 · Wagner Paul A. · Aug 27, 2026